SkinBioTherapeutics (LON:SBTX) Trading Up 10.2% – Here’s What Happened

SkinBioTherapeutics plc (LON:SBTX) shares were up 10.2% during mid-day trading on Friday . The stock traded as high as GBX 12.50 ($0.16) and last traded at GBX 12.40 ($0.16). Approximately 2,169,667 shares were traded during mid-day trading, an increase of 147% from the average daily volume of 877,841 shares. The stock had previously closed at GBX 11.25 ($0.15).

SkinBioTherapeutics Stock Performance

The company has a 50 day moving average price of GBX 11.97 and a 200-day moving average price of GBX 10.63. The company has a current ratio of 6.57, a quick ratio of 10.01 and a debt-to-equity ratio of 2.66. The company has a market cap of £28.25 million, a P/E ratio of -562.50 and a beta of 2.01.

SkinBioTherapeutics Company Profile

SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis.